The glycogen is a highly branched polysaccharide: the compact form in which cells store glucose, ready to be converted into ATP when needed. It is also present in the skin, where it fuels renewal processes, and its availability decreases with age.
What we use is phytoglycogen extracted from a variety of non-GMO sweet corn, chemically identical to animal glycogen but plant-derived, obtained through a water-based process. The difference compared with other corn polysaccharides lies in the branching: amylopectin branches every twenty glucose units, while phytoglycogen branches every ten. This density gives it a spherical shape that binds a great deal of water without increasing the formula's viscosity.
The rationale is energetic, not functional: it does not add an action; it enables cells to carry out their own. In the manufacturer's (Mibelle Biochemistry) tests on cultured fibroblasts, the greater availability of ATP resulted in higher production of hyaluronic acid and type I collagen. These are the supplier's laboratory data, not independent studies.
In LeLang formulas, it is found in the anti-dark-spot sunscreen serum, where the logic is to apply energy to defense: sun-exposed skin has to clear more damaged molecules than usual, and clearing them costs ATP. It works particularly well alongside hyaluronic acid, with which a synergy was measured—the two together, each at half the dose, perform better than either one alone at the full dose.
One clarification is worth making: it has nothing to do with glycation, which concerns circulating simple sugars and their binding to structural proteins. Here, the glucose is already packaged and intended for cellular metabolism, and it supports the skin barrier instead of compromising it.
